Ross Baker

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism

Agnes Lee, Frederick R. Rickles, Jim A. Julian et al. · Journal of Clinical Oncology · 2005 · 453 citations · Full text

Medicine, Oncology, Pharmacology +13

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 352 citations · Full text

Medicine, Hematology, Immunology +14

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

Helen Fogarty, Liam Townsend, Hannah Morrin et al. · Journal of Thrombosis and Haemostasis · 2021 · 342 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +11